Robert Wasserman
Stock Analyst at Benchmark
(3.13)
# 1,109
Out of 4,893 analysts
113
Total ratings
42.59%
Success rate
1.84%
Average return
Main Sectors:
Stocks Rated by Robert Wasserman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Reiterates: Buy | $75 | $52.59 | +42.61% | 7 | Jun 5, 2025 | |
| KMDA Kamada | Reiterates: Buy | $15 | $7.87 | +90.60% | 2 | May 15, 2025 | |
| OABI OmniAb | Reiterates: Buy | $6 | $2.20 | +172.73% | 9 | May 12, 2025 | |
| ITGR Integer Holdings | Maintains: Buy | $150 → $140 | $120.47 | +16.21% | 11 | Apr 25, 2025 | |
| XOMA XOMA Royalty | Initiates: Buy | $35 | $27.36 | +27.92% | 1 | Apr 17, 2025 | |
| IPA ImmunoPrecise Antibodies | Reiterates: Speculative Buy | $3 | $1.92 | +56.25% | 6 | Apr 1, 2025 | |
| ABCL AbCellera Biologics | Reiterates: Hold | n/a | $4.22 | - | 6 | Mar 3, 2025 | |
| HALO Halozyme Therapeutics | Reiterates: Buy | $75 | $56.58 | +32.57% | 9 | Feb 20, 2025 | |
| BLFS BioLife Solutions | Reiterates: Buy | $30 | $22.29 | +34.59% | 6 | Dec 19, 2024 | |
| ANEB Anebulo Pharmaceuticals | Reiterates: Speculative Buy | $8 | $1.74 | +359.77% | 6 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $3.73 | +34.05% | 3 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $12 | $7.33 | +63.71% | 17 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $2.91 | - | 7 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $129.82 | - | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $12 | $0.31 | +3,780.98% | 6 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $41.13 | +9.41% | 6 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $4 | $3.91 | +2.30% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $4 | $0.24 | +1,547.45% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $75 | $1.99 | +3,668.84% | 2 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $200.96 | - | 3 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $580 | $419.88 | +38.13% | 1 | Jul 16, 2021 |
Bio-Techne
Jun 5, 2025
Reiterates: Buy
Price Target: $75
Current: $52.59
Upside: +42.61%
Kamada
May 15, 2025
Reiterates: Buy
Price Target: $15
Current: $7.87
Upside: +90.60%
OmniAb
May 12, 2025
Reiterates: Buy
Price Target: $6
Current: $2.20
Upside: +172.73%
Integer Holdings
Apr 25, 2025
Maintains: Buy
Price Target: $150 → $140
Current: $120.47
Upside: +16.21%
XOMA Royalty
Apr 17, 2025
Initiates: Buy
Price Target: $35
Current: $27.36
Upside: +27.92%
ImmunoPrecise Antibodies
Apr 1, 2025
Reiterates: Speculative Buy
Price Target: $3
Current: $1.92
Upside: +56.25%
AbCellera Biologics
Mar 3, 2025
Reiterates: Hold
Price Target: n/a
Current: $4.22
Upside: -
Halozyme Therapeutics
Feb 20, 2025
Reiterates: Buy
Price Target: $75
Current: $56.58
Upside: +32.57%
BioLife Solutions
Dec 19, 2024
Reiterates: Buy
Price Target: $30
Current: $22.29
Upside: +34.59%
Anebulo Pharmaceuticals
Nov 19, 2024
Reiterates: Speculative Buy
Price Target: $8
Current: $1.74
Upside: +359.77%
Nov 12, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $3.73
Upside: +34.05%
Nov 7, 2024
Maintains: Buy
Price Target: $8 → $12
Current: $7.33
Upside: +63.71%
Nov 4, 2024
Reiterates: Hold
Price Target: n/a
Current: $2.91
Upside: -
Aug 5, 2024
Reiterates: Hold
Price Target: n/a
Current: $129.82
Upside: -
Jul 11, 2024
Reiterates: Speculative Buy
Price Target: $12
Current: $0.31
Upside: +3,780.98%
May 29, 2024
Reiterates: Buy
Price Target: $45
Current: $41.13
Upside: +9.41%
Mar 7, 2024
Reiterates: Speculative Buy
Price Target: $4
Current: $3.91
Upside: +2.30%
Mar 6, 2024
Reiterates: Speculative Buy
Price Target: $4
Current: $0.24
Upside: +1,547.45%
Apr 6, 2023
Reiterates: Speculative Buy
Price Target: $75
Current: $1.99
Upside: +3,668.84%
Oct 24, 2022
Downgrades: Hold
Price Target: n/a
Current: $200.96
Upside: -
Jul 16, 2021
Initiates: Buy
Price Target: $580
Current: $419.88
Upside: +38.13%